December 20, 2024
XEN-D0501, a transient receptor potential vanilloid 1 (TRPV1) antagonist, is gaining attention for its potential as an oral tablet to treat type 2 diabetes, obesity, and […]
December 20, 2024
LONDON (Reuters) -Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped overweight patients cut their weight by 22.7% in a late-stage trial, below […]
December 20, 2024
Although universal coverage of continuous glucose monitoring (CGM) devices in 2021 led to improved care for children with diabetes in British Columbia, equity gaps for the […]
December 20, 2024
Estimation of cardiovascular risk (CVR) in individuals living with type 1 diabetes (T1D) was a key topic presented by Sophie Borot, MD, from Besançon University Hospital, […]
December 19, 2024
TOPLINE: Perfluorohexanoic acid (PFHxA) is found in fluoroelastomer watch bands at concentrations of up to 16,662 ng/g, highlighting the need for further research on dermal absorption […]
December 18, 2024
TOPLINE: Overall national compliance with National Institute for Health and Care Excellence (NICE) guidelines for diabetic foot referral and screening was good. Integrated care boards (ICBs) […]
December 18, 2024
TOPLINE: Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled human […]
December 18, 2024
LONDON (Reuters) – Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds, the latest […]
December 17, 2024
The US Food and Drug Administration has approved crinecerfont (Crenessity) for use in combination with glucocorticoids in the treatment of adults and children aged 4 years […]